Home >Products> Spectrum | HPLC | GC | MS >HPLC / FPLC > Sepax GP-C18 Columns
Spectrum | HPLC | GC | MS:  Spectrophotometers   HPLC / FPLC   Gas Chromatograph   Mass Spectrometers   Gas Generator Systems   Ultraviolet Detectors  
Sepax GP-C18 Columns
Sepax GP-C18 Columns
Place of Origin:
United States
Brand:
Sepax Technologies, Inc.
Model:
Price:
Hits:
1205 
Updated:
4/1/2013
  • Product Detail
  • Company Profile

    Description 

    GP-C18 uses full coverage bonded silica packing, which provides exceptionally high stability. 

    The unique mono-functional bonding chemistry of GP-C18 avoids the formation of multiple C18 layers. Such uniform stationary phase 

    allows the separation 

    to achieve high selectivity and high efficiency.

    Packing 


    Silica:

    Spherical, high purity (<10 ppm metals)

    Pore size:

    120Å

    Particle size:

    1.8, 2.2, 3, 4, 5, 7, and 10 µm

    Pore volume:

    1.0 ml/g

    Surface area:

    300 m²/g

    Phase structure:

    Monomeric and fully endcapped

    % Carbon:

    17%

    Characteristic

     

    · Highly controlled chemistry of monolayer formation and end-capping

    · Extremely high column-to-column reproducibility

    · High selectivity and efficiency for separations

    · Suitable for separations of acidic, neutral and basic organic compounds, 

    as well as pharmaceuticals, peptides, and others

    · Recommended for separations in organic or mixed organic/aqueous mobile phases.

     

     

     

    Stability

    SepaxGP-C18 uses full coverage bonded silica packing, which provides exceptionally 

    high stability. Figure below

     shows the highly reproducible retention time for three standard compounds: aniline,

     anisole and toluene

     after 13,000 column volume runs in a mobile phase of 85% methanol and 15% water. 

    Such high stability allows SepaxGP-C18 extremely suitable for validation of various analytes.

    Selectivity for GP-C18 and the Competitors' C18 Phases

    Selectivity is very important for detection of the components of low abundance and

     impurities from 

    the analysis of pharmaceuticals in the real applications. The comparative tests shown

     below from the method development of 

    a drug molecule clearly demonstrated that GP-C18 is among the best products for high selectivity and sensitivity in detecting low 

    abundant components and the impurities.

    (Courtesy of Dr. Fang Liu, Novartis)

    Conditions

    Column:

    Inertsil ODS-3, 3 µm (Varian)
    Xterra RP18, 3.5 µm (Waters)
    Suplex PKB-100, 5 µm (Supelco)
    Sepax GP-C18, 3 µm

    Mobile phase:

    A: 99% Boric buffer (5.0 mM, pH 7.0)/1% Acetonitrile
    B: 40% Boric buffer (5.0 mM, pH 7.0)/60% Acetonitrile

    Gradient:

    0-3 min (100% A); 3-38min (0-100%B); 38-43 min (100% B)

    Column Temperature:

    50 °C

    Flow rate:

    1.0 mL/min

    Detection wavelength:

    210 nm

    Sample:

    A real pharmaceutical sample (undisclosed)

    bio-equip.cn
    Profile

    Sepax Technologies, Inc., a privately held company, was founded in Delaware, USA in November 2002. It develops and manufactures HPLC consumables, bulk media, and equipment in liquid chromatography for chemical and biological separations. It is a fast growing technology company and owns patents, proprietary technologies and know-how. Sepax has emerged as a leader in the biological separation industry in the global market.
    Business strategies

    Sepax Technologies, Inc. develops innovative HPLC consumables, bulk media, and instruments to solve separation challenges in the global market. We provide solution-based products by closely working with our customer scientists in pharmaceuticals, biopharmaceuticals, research institutes and government labs. Our strong technical team develops various methods with our customers to analyze complex biological molecules. As a leader in the biological separation industry, we constantly develop the best bio-separation technologies and products for our global customers. We have reached a competitive position globally in fast growing regions.
    Vision Statement

    To become a technology leader in the biological separation industry in the global market and provide solution based products and services for our customers.
    Operation

    Sepax Technologies, Inc.
    Our company headquarter in Delaware is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development of separation resin technologies and instrumentation, production of HPLC resins, columns and CE consumables. It is also the marketing and sales center for our US and global markets.


    Sales
    Domestic
    Audrey Fisher
    Field Sales Account Manager
    (Northern CA areas, UT, CO, OR)
    Direct Phone: 925-324-5223
    Email: afisher@sepax-tech.com
    Kathleen Falls
    West Coast Regional Manager
    (All other CA areas, WA, TX, AZ, NM, MI)
    Direct Phone: 323-228-0004
    Email: kfalls@sepax-tech.com
    Michael Hunnewell
    Field Sales Account Manager
    (MA, RI, NH, CT, NY)
    Direct Phone: 302-650-3955
    Email: mhunnewell@sepax-tech.com
    Colleen Callahan
    Midwest Account Manager
    (WI, IL, IN, OH, MO)
    Direct Phone: 302-366-1101, ext 106
    Cell Phone: 302-339-8747
    Email: ccallahan@sepax-tech.com
    All other areas, please contact
    Helen Gu
    Vice President, Sales
    Direct phone: 302-650-3909
    Email: hgu@sepax-tech.com
    International
    Tingting Wu
    Executive Account Manager/Marketing
    Phone: 302-366-1101, ext 115
    Email: twu@sepax-tech.com
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.